Bovie Medical Co. (BVX) Position Reduced by Emerald Mutual Fund Advisers Trust

Emerald Mutual Fund Advisers Trust cut its position in Bovie Medical Co. (AMEX:BVX) by 2.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 490,000 shares of the medical device company’s stock after selling 10,000 shares during the period. Emerald Mutual Fund Advisers Trust owned about 1.59% of Bovie Medical worth $1,210,000 at the end of the most recent reporting period.

Separately, Cowen Prime Services LLC raised its stake in shares of Bovie Medical by 62.3% in the first quarter. Cowen Prime Services LLC now owns 81,778 shares of the medical device company’s stock valued at $218,000 after buying an additional 31,378 shares during the period.

Bovie Medical Co. (AMEX:BVX) opened at 2.41 on Friday. The firm has a 50 day moving average of $2.47 and a 200-day moving average of $2.65. The company’s market capitalization is $74.37 million. Bovie Medical Co. has a 52-week low of $1.87 and a 52-week high of $5.75.

Bovie Medical (AMEX:BVX) last released its quarterly earnings data on Wednesday, August 2nd. The medical device company reported ($0.04) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.03) by $0.01. Bovie Medical had a negative net margin of 13.35% and a negative return on equity of 21.74%. The company had revenue of $9.80 million for the quarter, compared to analyst estimates of $8.60 million. Equities analysts expect that Bovie Medical Co. will post ($0.11) EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Bovie Medical Co. (BVX) Position Reduced by Emerald Mutual Fund Advisers Trust” was reported by Community Financial News and is the property of of Community Financial News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.com-unik.info/2017/08/19/emerald-mutual-fund-advisers-trust-has-1-21-million-position-in-bovie-medical-co-bvx-updated-updated.html.

Separately, Zacks Investment Research lowered shares of Bovie Medical from a “hold” rating to a “sell” rating in a research report on Thursday.

Bovie Medical Company Profile

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Institutional Ownership by Quarter for Bovie Medical (AMEX:BVX)

What are top analysts saying about Bovie Medical Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Bovie Medical Co. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit